Cantrixil: Advancing a Molecule’s Career with a Cyclodextrin Carrier
The success story of Cantrixil, a potent anti-cancer drug candidate, has been followed on our blog for years, and now
Tag: Cantrixil
Cantrixil’s Career Shift: Orphan Drug Encapsulated in Alpha-Cyclodextrin Changes Hands (and Cyclodextrin)
On 31 March, 2025, Kazia Therapeutics (Australia) Announced sale of intellectual property and trademarks rights for Cantrixil, a product that